Featured Videos

In 2021, GEN and the Rosalind Franklin Society hosted a webinar in which Katalin Karikó, PhD, walked through the history of mRNA and the advances that led to its role in the COVID-19 vaccine, including the discovery of the critically important modifications. At the time, Karikó had been named the winner of the Vilcek Foundation award. Now, together with Drew Weissman, MD, PhD, she is the most recent winner of the Nobel Prize in Physiology or Medicine.

Nobel Winner Katalin Karikó Shared mRNA Vaccine Story with GEN, Mid-Pandemic

After spending three terrific days in Boston, covering the BPI meeting, the GEN team is heading back home. Right before catching his train, John Sterling, Editor-in-Chief at GEN, joined Julianna LeMieux, PhD, Deputy Editor-in-Chief, and Kevin Davies, PhD, GEN‘s Editor at Large, to share their impressions of what they had learned over the past few days.

Bioprocessing in Beantown: GEN Reports Live from Day 2 at BPI

GEN September 2023 issue cover

It’s September, that time of year when back-to-school feelings come over us whether we’re enrolled in school or not. In keeping with those feelings, GEN is posting a course selection guide, or what we’re normally inclined to call a table of contents. And, yes, there’s a lot of required reading: epigenome editing, nonviral gene therapy delivery systems, liquid biopsies, noncanonical amino acids, and cryogenic electron microscopy. You can take a recess whenever you like, but don’t miss the pep rally, our listing of the top 10 biopharma clusters. It may seem retrospective. But it actually asks us to consider how the interregional competition to accommodate life sciences companies will play out, given current trends in NIH funding, VC funding, patents, laboratory space, and employment. Whichever region you’re in, stay full of that old school spirit. And pick up some extra credit by reading editorials on digital biomanufacturing, bioinformatics challenges, and chemotherapy shortages.